AlphaGalileo

KAIST Demonstrates Potential to Predict Drug Side Effects and Acute Kidney Injury Using a Small Chip

Rhabdomyolysis is a condition in which muscle damage—often caused by drug intake—can lead to impaired kidney function and ...
News-Medical.Net on MSN

Unveiling genetic links between schizophrenia and osteoporosis

A comprehensive genetic investigation led by Dr. Feng Liu at Tianjin Medical University General Hospital has uncovered ...
News-Medical.Net on MSN

Jumping genes reshape cancer genomes through 3D chromatin interactions

Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE-1 in shaping the cancer genome structure and regulation.
C&EN

α-Gal causes tick-related meat allergies—it could also be therapeutic

As people with α-gal syndrome seek to boost awareness, researchers are looking to harness the molecule for new therapies ...

LoQus23 Therapeutics nominates LQT-23 as first-in-class, oral drug candidate for Huntington's Disease

LQT-23 is a potent, highly differentiated, first-in-class allosteric small molecule inhibitor of MSH3/MutSß Unique mechanism of action with potential to slow or stop the progression of HDCAMBRIDGE ...

IGC Pharma, Inc.: IGC Pharma Aligns Fiscal Year with Calendar Year to Enhance U.S. Investor Transparency and Comparability

POTOMAC, MD / ACCESS Newswire / January 6, 2026 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage pharmaceutical company leveraging Artificial Intelligen ...